; (ii) reducing the risk of multifetal gestation by limiting the number of embryos replaced in the initial P.L.Matson 1 and B.A.Lieberman cycle (Nijs et al., 1993) (Wada et al., 1992 (Wada et al., , 1993 Pattinson et al., 1994) ; (iv) in a donor oocyte A total of 364 consecutive patients requesting in-vitro programme, enabling a second human immunodeficiency virus fertilization (IVF) treatment were divided randomly into antibody test to be performed on the oocyte donor 6 months two groups. In the first group, two embryos in the original later, before the embryos are released from 'quarantine' for IVF cycle were allowed to divide prior to transfer, with any replacement (Hamer et al., 1994); and (v) prior to chemotherapy remaining embryos being cryopreserved at the pronucleate as a means of preserving the patient's future fertility potential (PN) stage. In the second group, all the embryos were (Winkel and Fossum, 1993; Brown et al., 1996). allowed to divide to the early cleavage (EC) stage, and the The use of embryo cryopreservation by IVF units is increasbest two replaced; any suitable remaining embryos were ing rapidly, such that in 1989~700 pregnancies had been frozen at the 2-to 4-cell stage. A total of 134 cycles (36.8%) achieved worldwide (Van Steirteghem and Van Den Abbeel, fulfilled the study criteria for a fresh embryo replacement 1990). Indeed, in 1993 in the UK alone, Ͼ764 live births were and supernumerary embryos cryopreserved. In the PN reported from 6004 frozen-thawed embryo transfers (Human group, 72 out of 182 (39.6%) patients had a fresh embryo Fertilization and Embryology Authority, 1995). replacement accompanied by embryo cryopreservation,
Introduction or glass ampoules. The methods for thawed embryo replacements also vary, with the use of natural cycles (Cohen et al., The initial success of embryo cryopreservation (Trounson and Mohr, 1983) and subsequent pregnancy outcome (Zeilmaker 1986 (Zeilmaker , 1988a Testart et al., 1987; Fugger et al., 1988) or exogenous steroids (Jaroudi et al., 1991; Muasher et al., 1991 Muasher et al., ). et al., 1984 has resulted in many in-vitro fertilization (IVF) groups adopting their own freezing programmes with equal
The ultimate reason for embryo cryopreservation must be to achieve a successful pregnancy. The relative merits of success (Cohen et al., 1985a) . The delivery of healthy babies (Wada et al., 1994; Sutcliffe et al., 1995) has confirmed the cryopreserving PN, EC or blastocyst stage embryos for subsequent thawing and replacement to maximize the pregnancy short-term safety of the technique, and the value of embryo cryopreservation can be seen in several clinical situations, rate is an important consideration for every IVF unit. Despite voluminous reports relating human embryo freeze-thaw surnamely (i) allowing patients an increased chance of pregnancy by the subsequent replacement of thawed embryos, without vival to the stage of development and the method of cryopreservation used, there is no conclusive evidence that the stage the need for additional ovarian stimulation and oocyte recovery concentration of 100 000/ml. Normal fertilization was characterized of development at cryopreservation provides a clear advantage by the visualization of two clear pronuclei. Any oocyte containing with respect to successful pregnancy outcome (Gelety and three or more pronuclei, which was assumed to indicate polyspermy, Surrey, 1993) . Work by Fugger (1989) has demonstrated a was discarded.
clear advantage for the cryopreservation of embryos at the PN On day 2 (48-50 h post-oocyte retrieval) the embryos had usually stage, compared with EC and blastocyst stages, with pregnancy cleaved to the EC stage. The embryos were scored for cell number rates of 17.4, 12.5 and 4.5% respectively. These findings have and quality using the following criteria: grade A, the blastomeres had been supported by subsequent investigations demonstrating an equal size, but allowance was made for blastomeres during increased pregnancy and implantation rates with embryos division, and no anucleate fragments were present; grade B, not all cryopreserved at the PN stage (Gordts et al., 1990; the blastomeres had an equal size and anucleate fragments were et al Demoulin et al., 1991; Veeck et al., 1993) . In present in Ͻ20% of the embryo volume; and grade C, the embryos were dark and contained Ͼ20% anucleate fragments by volume.
contrast, Van den Abbeel et al. (1988) found no difference in A further injection of 2000 IU HCG was given on day 4 postpregnancy rates between PN and EC stage embryos.
oocyte recovery for luteal phase support.
The objectives of this prospective randomized study were to describe and compare the relative merits of embryo cryoEmbryo cryopreservation and thawing protocols preservation at the PN and EC stages and to determine the The cryopreservation and thawing of embryos at the PN and EC effect on the pregnancy rate in both the initial IVF cycle and stages were performed using PROH (Sigma, Poole, UK)/sucrose in the subsequent transfer of thawed embryos.
EFM1 (Medi-Cult, Redhill, UK) freezing medium and a fast freezefast thaw method (Lassalle et al., 1985; Troup et al., 1990) . Only grade A and B EC embryos were frozen; grade C embryos were
Materials and methods
deemed to be unsuitable and discarded.
Patients
The cryopreservation procedure involved exposure of the embryos to the cryoprotectants through a series of solutions. The process was All patients requesting IVF treatment at the Regional IVF Unit, performed at room temperature. The freezing solutions (F) were first St Mary's Hospital, Manchester, UK in 1994, following informed made up as follows: F1, EFM1; F2, EFM1 ϩ 1.5 M PROH; and F3, consent, were randomly assigned to either a PN or EC embryo EFM1 ϩ 1.5 M PROH ϩ 0.1 M sucrose. The embryos were washed cryopreservation group. Patients requesting gamete intra-Fallopian initially in F1, and then transferred to F2 for 10-15 min. Finally they transfer (GIFT), single embryo replacement or requiring micromanipuwere transferred to F3, loaded immediately into freezing straws lation of their oocytes were excluded from the study. A maximum of and plugged. The straws were then transferred to a programmable two fresh or frozen embryos were replaced throughout the study for controlled-rate freezer and frozen at the following rates: ramp 1, each patient. All the patients were asked at the time of recruitment -2°C/min to -7°C; ramp 2, hold for 10 min; ramp 3, -0.3°C/min to to return within 6-8 months for a frozen embryo replacement cycle -30°C; ramp 4, hold for 5 min; ramp 5, -50°C/min to -190°C; ramp if their treatment was unsuccessful so as to minimize the interval 6, hold for 20 min. between treatment cycles.
An embryo was thawed by removing the straw from liquid nitrogen Ovarian stimulation and leaving it at room temperature for 40 s. It was then immersed in a 30°C water bath for 1 min. The embryo, now at room temperature, Treatment was commenced 7 days before the next expected menstrual was passed through a series of solutions (T): T1, EFM1 ϩ 0.2 M period, and this was defined as day 1 of treatment. Pituitary desensitizasucrose ϩ 1 M PROH; T2, EFM1 ϩ 0.2 M sucrose ϩ 0.5 M PROH; tion using the gonadotrophin-releasing hormone agonist buserelin T3, EFM1 ϩ 0.2 M sucrose; and T4, EFM1. (Suprefact; Hoechst Roussel Ltd, Uxbridge, UK) began by the daily A PN stage embryo was considered to have survived the freezeadministration of 500 mg s.c. from day 1; this continued until the thaw process if there was no obvious damage to the zona pellucida ovulatory trigger. On day 12 of treatment the patient was assessed and if it divided after overnight culture. EC embryos were cultured for pituitary desensitization and ovarian suppression. The criteria for 2-4 h after thawing before replacement, and were considered to used for adequate suppression were: (i) no ovarian follicles or cysts have survived the freeze-thaw process if at least 50% of the Ͼ10 mm in diameter and (ii) the onset of menses. If both criteria blastomeres remained intact. were not met on day 12, then the patient returned weekly until pituitary desensitization and ovarian suppression were achieved.
Replacement cycles Upon fulfilling the above criteria, ovarian stimulation commenced with daily injections of human menopausal gonadotrophin (HMG; Two protocols were followed for the replacement of frozen-thawed embryos: (i) The first protocol was a natural cycle which involved Pergonal; Serono Laboratories, Welwyn Garden City, UK; or Humegon; Organon Laboratories, Oss, The Netherlands), usually two the daily measurement of serum luteinizing hormone (LH; LH Miaclone; Biodata Diagnostics, Rome, Italy) to detect the LH surge ampoules (150 IU follicle stimulating hormone). A higher dose of HMG was given to women with a previous poor response to the two (i.e. a LH concentration Ͼ12 mIU/ml). In this way the embryos and the stage of endometrial development were synchronized (Mandelampoules dose. From day 8 of stimulation onwards, the ovarian response was monitored daily by serum oestradiol measurements and baum et al., 1988) . Once the LH surge was observed, PN embryos were thawed 2 days later and, if suitable, replaced on the third day. vaginal ultrasonography. When three or more follicles measured Ͼ20 mm in diameter, ovulation was triggered with the administration of EC embryos were thawed and replaced on the third day after the LH surge; (ii) Following desensitization with buserelin, endometrial 10 000 IU human chorionic gonadotrophin (HCG). The oocytes were collected 36 h later using ultrasound oocyte retrieval. If the patient development was stimulated by the administration of exogenous steroids, namely oral oestradiol valerate (Climaval; Sandoz Pharmawas deemed to be at risk of developing OHSS (Wada et al., 1992 (Wada et al., , 1993 , then all the embryos were cryopreserved at the PN stage ceuticals, Camberley, UK) and vaginal progesterone (Cyclogest; Hoechst Roussel Ltd) ( Table I) . and stored.
The oocytes were inseminated 4-6 h after retrieval using a sperm A retrospective study had previously concluded that there was no Two types of cumulative livebirth result, from the original IVF cycle and subsequent frozen embryo cycles, were calculated. The anticipated HMG ϭ human menopausal gonadotrophin; PN strategy ϭ embryos frozen cumulative livebirth rate (Veeck et al., 1993; Wang et al., 1994) as at the pronuclear stage; EC strategy ϭ embryos frozen at the early cleavage well as the actual cumulative livebirth rate using life -table analysis stage.
( Cooke et al., 1981) were used. Veeck et al. (1993) and Wang et al. (1994) employed a method of calculating the anticipated cumulative livebirth rate using the fresh, 
Patient details
number of embryos frozen per patient or any other overall A total of 364 patients entering the study were randomly parameter. divided into the two cryopreservation strategies. From these
The livebirth rate with the EC strategy (27.4%) was significpatients, 134 (36.8%) treatment cycles met both study criteria antly higher than that with the PN strategy (11.1%; P Ͻ 0.05) of having an embryo replacement and also embryo cryopreserv- (Table III) . This may have been because of the significantly ation. There was no difference in the demographic details of higher pregnancy wastage with the PN strategy (42.8%) than the two groups or the response to ovarian stimulation, as with the EC strategy (10.5%; P Ͻ 0.05). The implantation shown in Table II. rate also appeared to be higher with the EC strategy (15.3%; 19/124) than with the PN strategy (10.1%; 14/138), although Source cycle results this did not reach statistical significance. The two study groups (PN and EC strategies) contained 72 and 62 patients respectively (Table III) . The overall fertilization Survival and transfer of thawed embryos rate in the EC strategy compared with the PN strategy was significantly different (P Ͻ 0.01). There was no significant
Pronucleate strategy A total of 55 women returned for 68 cycles in which embryos difference between the two groups with respect to the number of oocytes retrieved, the number of embryos replaced, the were thawed (Table IV) . Of these thaws, 59 (86.8%) resulted GIFT units (Veeck et al., 1993; Wang et al., 1994) . Usually at the PN (Veeck et al., 1993) or EC (Wang et al., 1994) stage.
HRT ϭ hormone replacement therapy.
However, direct comparison between the data has been difficult, because of differing individual clinic stimulation regimens, embryo culture conditions, freezing protocols, cryoprotectants in at least one embryo surviving and being replaced. A total and interpretation and documentation of the results. of 129 embryos were thawed in the 68 cycles, with 96 (74.4%)
The expression of the results of embryo cryopreservation surviving and being replaced. varies enormously. Indeed Jones et al. (1995) described nine Early cleavage strategy separate formulae and concluded that five of these were A total of 40 patients had embryos thawed on 50 occasions. essential to give a comprehensive evaluation of the efficacy This resulted in at least one embryo being replaced in 46 of cryopreservation. However, in our study, formulae were (92.0%) of the cycles. These patients had a total of 102 selected to allow the following parameters to be clearly embryos thawed, of which 79 (77.4%) survived and were represented and compared: (i) the survival and implantation replaced (Table IV) .
of individual embryos; (ii) the pregnancy rate achieved at each transfer of frozen-thawed embryos; (iii) the actual cumulative Implantation and outcome after transfer of thawed embryos pregnancy rate achieved from the original collection of oocytes, Pronucleate strategy to include all transfers of resulting fresh and frozen embryos; Overall, 22.0% of embryo transfers resulted in a positive and (iv) the projected cumulative pregnancy rate, to include pregnancy test, with 84.6% of these resulting in a live embryos still remaining frozen, given that not all patients will birth ( Table V) . The performance of the individual embryos have used all their embryos at the time of analysis. transferred was that 14.6% of embryos transferred implanted
It is important to note that embryo cryopreservation affected and developed into a live infant. This includes the only multiple 40.9% (134/328) of treatment cycles commenced and 47.9% implantation recorded in the study.
(134/280) of cycles reaching oocyte collection; 62.0% (134/ 216) of patients reaching embryo replacement generated suffiEarly cleavage strategy Overall, 13.0% of cycles resulted in a positive pregnancy test, cient embryos for cryopreservation. Therefore, the effect of embryo cryopreservation upon an IVF unit is substantial, and with 50.0% of these going on to a live birth. Of the embryos implanted, 7.6% went on to develop into a live baby (Table V) .
the benefits to those patients with supernumerary embryos must not be taken lightly.
Cumulative livebirth rates
There was no significant difference between the embryo survival/replacement rates for the two embryo development It can be seen from Table VI that the actual cumulative livebirth rate for IVF cycles after one fresh and two frozenstages. However, this figure does not have the same definition for both groups, because it is essentially a true embryo survival thawed embryo replacements was the same irrespective of the stage at which the embryos were cryopreserved. There was also rate for the PN stage, whereas it represents an embryo replacement rate for the EC stage. For a PN embryo to be In summary, our study has shown that the PN strategy compromises the fresh embryo replacement cycle but maximreplaced it first has to divide following culture overnight, and therefore to survive totally the freeze-thaw process. In the izes the potential of the frozen embryos. This would suggest that couples with low numbers of embryos (four or fewer) case of EC embryos, all the embryos replaced were said to have survived. However, in some cases only 50% of the would be best served by leaving all embryos until the day of embryo transfer and cryopreserving only suitable supernumerblastomeres of an individual embryo will have survived the freeze-thaw process.
ary embryos (i.e. to maximize the potential of a fresh embryo replacement). However, couples with a large number of fertilThe implantation rate of fresh embryos resulted in significantly more live births with the EC strategy compared with the ized oocytes would probably improve their overall chance of achieving a viable pregnancy by having some embryos frozen at PN strategy (P Ͻ 0.05), with almost a 3-fold increase. Similar results were shown by Sunde (1995) , who demonstrated the PN stage (to maximize the performance of the subsequently thawed embryos) and leaving the remainder until the day of that selection of the best embryos (Ͻ10% volume anuclear fragments) for replacement resulted in an~3-fold higher embryo transfer. average implantation rate than when replacing inferior quality embryos. The EC strategy allows the embryologist to choose References and replace the best embryos, whereas the PN strategy allows Al-Hasani, S., Ludwig, M., Gagsteiger, F. et al. (1996) Comparison of no choice because all the zygotes appear to be similar on the cryopreservation of supernumerary pronuclear human oocytes obtained after day after insemination.
intracytoplasmic sperm injection (ICSI) and after conventional in-vitro
The frozen embryo survival rates of the two strategies were fertilization. Hum. Reprod., 11, [604] [605] [606] [607] not significantly different. However, the outcome per cycle of Brown, J.R., Modell, E., Obasaju, M. et al. (1996) Natural cycle in-vitro fertilization with embryo cryopreservation prior to chemotherapy for the frozen embryo replacement suggested that freeze-thawed carcinoma of the breast. Hum. Reprod., 11, 1997-199. PN embryos result in almost twice the number of viable Check, J.H., Hoover, L., Nazari, A. et al. (1996) The effect of assisted pregnancies compared with the EC embryos; this was also hatching on pregnancy rates after frozen embryo transfer. Fertil. Steril., 65, [254] [255] [256] [257] reflected in a doubling of the implantation rate. value (Hull et al., 1992) . These studies, however, did not take Veeck et al. (1993) , to calculate the anticipated the pronucleate or multicellular stages. Hum. Reprod., 6, [799] [800] [801] [802] [803] [804] cumulative pregnancy rate, does not describe individual patient units, and similar results are now being achieved with the Gordts, S., Roziers, P., Campo, R. et al. (1990) Survival and pregnancy cryopreservation of embryos generated from intracytoplasmic outcome after ultrarapid freezing and thawing. Fertil. Steril., 53, [373] [374] [375] [376] sperm injection (Al-Hasani et al., 1996) . It has also been Hamer, F.C., Horne, G., Pease, E.H.E. et al. (1994) The quarantine of fertilised suggested that embryo implantation and pregnancy rates may donated oocytes. Obstet. Gynecol., 10, 1194 -1196 . Horne, G. (1995 A retrospective and prospective evaluation of different be improved using assisted hatching (Check et al., 1996) .
